Novyra Pharmachem share price today, results and news
Novyra Pharmachem was at ₹8.06 at 11:02 am IST on 18 Nov 2026, up 0.00% on the day. It is 51.3% below its 52-week high of ₹16.55 and 9.7% above its 52-week low of ₹7.35.
At a glance
- Previous close
- ₹8.06
- Open
- ₹8.06
- Day’s range
- ₹8.06 – 8.06
- Volume
- 0
Price refreshed every 15 minutes during market hours. Indicators use daily closes.
Earnings
Novyra Pharmachem quarterly results and earnings call
Latest results
Upcoming results
SEBI’s listing rules give companies 45 days after a quarter ends to publish results (60 days for the full year). The exact board-meeting date is announced to the stock exchanges beforehand.
Latest earnings call
Companies usually hold the call on the day of their results or the day after, and post the recording and transcript on their website.
Find the latest transcript (opens in a new tab)5 things to know about Novyra Pharmachem today
- Was at ₹8.06 at 11:02 am IST on 18 Nov 2026, up 0.00% on the day.
- Trades 51.3% below its 52-week high of ₹16.55 (23 Mar 2026) and 9.7% above its 52-week low of ₹7.35.
- 0 shares traded in the last session, 0.0× the 20-day average.
Share price vs Nifty 50
| Period | NOVYRA | Nifty 50 |
|---|---|---|
| 1 month | −25.58% | +10.31% |
| Share price (₹) | Q1 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | Q3 FY27 (to date) |
|---|---|---|---|---|---|---|
| Closing price | 5.60 | 15.55 | 14.97 | 10.70 | 8.71 | 8.06 |
| Change QoQ | −4.92% | +177.68% | −3.73% | −28.52% | −18.60% | −7.46% |
| High | 5.60 | 15.55 | 16.55 | 16.48 | 10.70 | 8.50 |
| Low | 5.60 | 5.88 | 14.97 | 10.70 | 8.71 | 7.35 |
| Share price (₹) | FY23 | FY24 | FY25 | FY26 | FY27 (to date) |
|---|---|---|---|---|---|
| Closing price | 9.70 | 3.34 | 5.89 | 14.97 | 8.06 |
| Change YoY | — | −65.57% | +76.35% | +154.16% | −46.16% |
| High | 9.82 | 9.70 | 8.90 | 16.55 | 16.48 |
| Low | 6.27 | 3.34 | 3.50 | 5.60 | 7.35 |
Share price by quarter and financial year from closing prices. The reported revenue, profit and EPS of Novyra Pharmachem will replace this table once added from the company’s results.
Technical indicators
Novyra Pharmachem technical indicators
Calculated from daily closing prices up to 18 Nov 2026. They describe past prices only and are not a forecast.
RSI compares recent gains with recent losses on a 0 to 100 scale. Readings above 70 are commonly described as overbought and below 30 as oversold.
The MACD line is below its 9-day signal line (−1.09). MACD tracks the gap between the 12-day and 26-day exponential averages.
The close is 18.0% below the average closing price of the last 20 trading days.
The close is 35.8% below the average closing price of the last 50 trading days.
The close is 8% of the way from the 52-week low (₹7.35, 13 Nov 2026) to the high (₹16.55, 23 Mar 2026).
0 shares traded in the last session, against a 20-day average of 400.
FAQ
Questions about Novyra Pharmachem
What is the share price of Novyra Pharmachem today?
Novyra Pharmachem was at ₹8.06 at 11:02 am IST on 18 Nov 2026, up 0.00% from the previous close of ₹8.06 on the BSE.
What is the 52-week high and low of Novyra Pharmachem?
In the last 52 weeks Novyra Pharmachem traded between a low of ₹7.35 on 13 Nov 2026 and a high of ₹16.55 on 23 Mar 2026. The last close is 51.3% below the high.
How has Novyra Pharmachem stock performed recently?
Based on closing prices up to 18 Nov 2026, Novyra Pharmachem shares are down 25.6% over one month.
What is the stock symbol and ISIN of Novyra Pharmachem?
Novyra Pharmachem is listed on the BSE under the symbol NOVYRA. Its ISIN is INE856E01019.
About this data
- Prices and indicators: last closing prices, updated 18 Nov 2026, 11:02 am IST.
- Headlines: linked to the publisher that reported them. We store only the headline, link and date.
Disclaimer: Marketasset is an information service and is not registered with SEBI as an investment adviser or research analyst. We do not publish our own analysis or ratings of any stock. Prices are the last closing prices, technical indicators are calculated from past prices, headlines link to the original publisher and company figures come from the company’s own published documents. Nothing here is a recommendation to buy, sell or hold any security.